These final results, together with a former report displaying that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like habits in mice,2 support the strategy of targeting ACKR3 as a singular way to modulate the opioid procedure, which could open new therapeutic avenues for opioid-linked Problems. By ticking this box and https://kemall813kgf6.webbuzzfeed.com/profile